Endocarditis Deaths Show Uneven Progress Across U.S. Groups
A retrospective analysis of CDC WONDER records found U.S. age-adjusted infective endocarditis mortality was nearly unchanged from 1999 to 2024, but the path was nonlinear. Death rates rose among younger and middle-aged adults, men, and nonmetropolitan residents, while falling among older adults, women, and metropolitan residents.
The review used national death-certificate data from CDC WONDER, counting records where infective endocarditis appeared anywhere on the certificate rather than only as the underlying cause. Across 1999–2024, the age-adjusted rate moved from about 4.2 to 4.1 per 100,000, but the path included flat or rising years, a decline, a plateau, a steep rise, and a sharp fall.
Subgroup figures diverged: rates fell for people 65 and older, women, and metropolitan residents, while they climbed for ages 15–44 and 45–64, men, and nonmetropolitan residents. The presenter noted that the data lacked individual clinical or behavioral details, limiting explanations; she suggested younger-adult patterns may relate to injection-drug-use-associated disease and changing exposures.
The findings could affect younger adults, men, and rural residents, who may face rising endocarditis death risk, while older adults and urban populations may see continued improvement. Because endocarditis needs timely specialist and addiction care, uneven access could shape outcomes. The study may prompt clinicians and health systems to look beyond national averages and consider local prevention, early diagnosis, and coordinated care, though it cannot prove causes or predict individual risk.